The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland

摘要

Genital warts, 90% of which are caused by human papillomavirus types 6 and 11, are a significant problem in the UK. The cost of managing genital warts was previously estimated at 52.4 pound million for 2010. The objective of this study was to estimate the cost of genital warts management up to 2012 in the UK and by jurisdiction. Population statistics and the number of reported genital warts cases in genito-urinary medicine clinics were obtained and extrapolated to 2012. Cases of genital warts treated in primary care were estimated from The Health Improvement Network database. The number of visits and therapy required were estimated by genito-urinary medicine experts. Costs were obtained from the appropriate national tariffs. The model estimated there were 220,875 genital warts cases in the UK in 2012, costing 58.44 pound million (265 pound/patient). It estimated 157,793 cases in England costing 41.74 pound million; 7468 cases in Scotland costing 1.90 pound million; 7095 cases in Wales costing 1.87 pound million; and 3621 cases in Northern Ireland costing 948,000 pound. The full National Health Service costs for the management of genital warts have never previously been estimated separately for each jurisdiction. Findings reveal a significant economic burden, which is important to quantify when understanding the value of quadrivalent human papilloma virus vaccination.